68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Carcinoma
In brief
This clinical trial studies the use of gallium-68 (68Ga)-DOTA-Bombesin as the imaging agent for positron emission tomography (PET)/magnetic resonance imaging (MRI), collectively PET-MRI, in patients with prostate cancer. PET uses a radioactive substance called 68Ga-DOTA-Bombesin, which attaches to tumor cells with specific receptors on their surfaces. The PET scanner takes pictures that capture where the radioactive drug is "lighting up" and attaching to tumor cells, which may help doctors recognize differences between tumor and healthy prostate tissue. MRI uses radio waves and a magnet to make a picture of areas inside the body. Using 68Ga-DOTA-Bombesin in diagnostic procedures, such as PET/MRI, may allow doctors to identify smaller tumors than standard imaging.
Key facts
- Study ID
- NCT02440308
- Run by
- Stanford University
- People needed
- 10
- Starts
- 2015-04-01
- Expected to finish
- 2015-06-30
- Last updated by the study team
- 2017-04-11
Who can join
Age: 19 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Provides written informed consent
- Known diagnosis of prostate cancer
- Patient has suspected recurrence based on biochemical data [prostate-specific antigen (PSA) > 2 ng/mL]
- Able to remain still for duration of each imaging procedure (about one hour)
You may not qualify if…
- Unable to provide informed consent
- Inability to lie still for the entire imaging time
- Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
- Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance
- Metallic implants
Where it is running
- Stanford University Hospitals and Clinics — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.